Related references
Note: Only part of the references are listed.Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progression
Eric P. Allain et al.
BRITISH JOURNAL OF CANCER (2020)
Adaptive RSK-EphA2-GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancer
Lidia Moyano-Galceran et al.
EMBO MOLECULAR MEDICINE (2020)
A novel gene panel for prediction of lymph-node metastasis and recurrence in patients with thyroid cancer
Emmanuelle M. L. Ruiz et al.
SURGERY (2020)
The LncRNA HOTAIRM1 Promotes Tamoxifen Resistance by Mediating HOXA1 Expression in ER plus Breast Cancer Cells
Clara Yuri Kim et al.
JOURNAL OF CANCER (2020)
ROCplot.org: Validating predictive biomarkers of chemotherapy/hormonal therapy/anti-HER2 therapy using transcriptomic data of 3,104 breast cancer patients
Janos T. Fekete et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
INHBA gene silencing inhibits gastric cancer cell migration and invasion by impeding activation of the TGF-β signaling pathway
Zong-Lin Chen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Next-generation characterization of the Cancer Cell Line Encyclopedia
Mahmoud Ghandi et al.
NATURE (2019)
Structural Adaptation in Its Orphan Domain Engenders Betaglycan with an Alternate Mode of Growth Factor Binding Relative to Endoglin
Sun Kyung Kim et al.
STRUCTURE (2019)
Betaglycan drives the mesenchymal stromal cell osteogenic program and prostate cancer-induced osteogenesis
Leah M. Cook et al.
ONCOGENE (2019)
Structural biology of betaglycan and endoglin, membrane-bound co-receptors of the TGF-beta family
Sun Kyung Kim et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2019)
The BioGRID interaction database: 2019 update
Rose Oughtred et al.
NUCLEIC ACIDS RESEARCH (2019)
Inhibins regulate peripheral regulatory T cell induction through modulation of dendritic cell function
Marisol de la Fuente-Granada et al.
FEBS OPEN BIO (2019)
CD105 (Endoglin) as negative prognostic factor in AML
Joseph Kauer et al.
SCIENTIFIC REPORTS (2019)
Inhibin Is a Novel Paracrine Factor for Tumor Angiogenesis and Metastasis
Priyanka Singh et al.
CANCER RESEARCH (2018)
Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis
Madelon Paauwe et al.
CLINICAL CANCER RESEARCH (2018)
Dually modified transmembrane proteoglycans in development and disease
Laura M. Jenkins et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2018)
Decreased TGFBR3/betaglycan expression enhances the metastatic abilities of renal cell carcinoma cells through TGF-β-dependent and-independent mechanisms
Jun Nishida et al.
ONCOGENE (2018)
Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets
Adam Nagy et al.
SCIENTIFIC REPORTS (2018)
Endoglin haploinsufficiency is associated with differential regulation of extracellular matrix production during skin fibrosis and cartilage repair in mice
Anas Alzahrani et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2018)
GATA4 inhibits cell differentiation and proliferation in pancreatic cancer
Yan Gong et al.
PLOS ONE (2018)
Betaglycan (TGFBR3) Functions as an Inhibin A, but Not Inhibin B, Coreceptor in Pituitary Gonadotrope Cells in Mice
Yining Li et al.
ENDOCRINOLOGY (2018)
Dysregulation of EGFR Pathway in EphA2 Cell Subpopulation Significantly Associates with Poor Prognosis in Colorectal Cancer
Mariangela De Robertis et al.
CLINICAL CANCER RESEARCH (2017)
GATA4 is highly expressed in childhood acute lymphoblastic leukemia, promotes cell proliferation and inhibits apoptosis by activating BCL2 and MDM2
Qiuguo Han et al.
MOLECULAR MEDICINE REPORTS (2017)
Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells
Robin M. Meyers et al.
NATURE GENETICS (2017)
Prognostic value of endoglin-assessed microvessel density in cancer patients: a systematic review and meta-analysis
Jinguo Zhang et al.
Oncotarget (2017)
Activin B Regulates Adhesion, Invasiveness, and Migratory Activities in Oral Cancer: a Potential Biomarker for Metastasis
Akihiro Kita et al.
JOURNAL OF CANCER (2017)
From big data to diagnosis and prognosis: gene expression signatures in liver hepatocellular carcinoma
Hong Yang et al.
PEERJ (2017)
Defining a Cancer Dependency Map
Aviad Tsherniak et al.
CELL (2017)
Dichotomous roles of TGF-β in human cancer
Jennifer J. Huang et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2016)
P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines
Gabriel Gallo-Oller et al.
CANCER LETTERS (2016)
Altering the Proteoglycan State of Transforming Growth Factor Type III Receptor (TRIII)/Betaglycan Modulates Canonical Wnt/-Catenin Signaling
Laura M. Jenkins et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Endoglin targeting inhibits tumor angiogenesis and metastatic spread in breast cancer
M. Paauwe et al.
ONCOGENE (2016)
Mutant p53 promotes tumor progression and metastasis by the endoplasmic reticulum UDPase ENTPD5
Fotini Vogiatzi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
HER2 testing in gastric cancer: An update
Lucas Faria Abrahao-Machado et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Loss of exogenous androgen dependence by prostate tumor cells is associated with elevated glucuronidation potential
Brenna M. Zimmer et al.
HORMONES & CANCER (2016)
Activin B induces human endometrial cancer cell adhesion, migration and invasion by up-regulating integrin β3 via SMAD2/3 signaling
Siyuan Xiong et al.
ONCOTARGET (2015)
Activin-A signaling promotes epithelial-mesenchymal transition, invasion, and metastatic growth of breast cancer
Mohsin Bashir et al.
NPJ BREAST CANCER (2015)
Inhibin at 90: From Discovery to Clinical Application, a Historical Review
Yogeshwar Makanji et al.
ENDOCRINE REVIEWS (2014)
EphA2 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer cells
J. Huang et al.
ONCOGENE (2014)
HOXA1 drives melanoma tumor growth and metastasis and elicits an invasion gene expression signature that prognosticates clinical outcome
J. Wardwell-Ozgo et al.
ONCOGENE (2014)
Serum Inhibin A and Inhibin B Levels in Epithelial Ovarian Cancer Patients
Pawel Walentowicz et al.
PLOS ONE (2014)
A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma
Syed Haider et al.
GENOME MEDICINE (2014)
Transforming growth factor beta receptor type III is a tumor promoter in mesenchymal-stem like triple negative breast cancer
Bojana Jovanovic et al.
BREAST CANCER RESEARCH (2014)
βarrestin2 interacts with TβRII to regulate Smad-dependent and Smad-independent signal transduction
Sarah McLean et al.
CELLULAR SIGNALLING (2013)
Therapeutic antitumor potential of endoglin-based DNA vaccine combined with immunomodulatory agents
M. Jarosz et al.
GENE THERAPY (2013)
Type III TGF-β receptor promotes FGF2-mediated neuronal differentiation in neuroblastoma
Erik H. Knelson et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
Neil E. Bhola et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Angiogenesis in Glioblastoma
Sunit Das et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
TβRIII/β-arrestin2 regulates integrin α5β1 trafficking, function, and localization in epithelial cells
K. Mythreye et al.
ONCOGENE (2013)
Significance of INHBA expression in human colorectal cancer
Miho Okano et al.
ONCOLOGY REPORTS (2013)
HOXA1 is overexpressed in oral squamous cell carcinomas and its expression is correlated with poor prognosis
Carolina Cavalcante Bitu et al.
BMC CANCER (2012)
Inhibin α-Subunit N Terminus Interacts with Activin Type IB Receptor to Disrupt Activin Signaling
Jie Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Identification of a 7-gene signature that predicts relapse and survival for early stage patients with cervical carcinoma
Long Huang et al.
MEDICAL ONCOLOGY (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
A Gene Signature for Predicting Outcome in Patients with Basal-like Breast Cancer
Robin M. Hallett et al.
SCIENTIFIC REPORTS (2012)
Endoglin expression in breast tumor cells suppresses invasion and metastasis and correlates with improved clinical outcome
L. A. Henry et al.
ONCOGENE (2011)
Type III TGF-β Receptor Enhances Colon Cancer Cell Migration and Anchorage-Independent Growth
Catherine E. Gatza et al.
NEOPLASIA (2011)
The physiological role of endoglin in the cardiovascular system
Jose M. Lopez-Novoa et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Elevation of Receptor Tyrosine Kinase EphA2 Mediates Resistance to Trastuzumab Therapy
Guanglei Zhuang et al.
CANCER RESEARCH (2010)
The type III TGF-β receptor suppresses breast cancer progression through GIPC-mediated inhibition of TGF-β signaling
Jason D. Lee et al.
CARCINOGENESIS (2010)
Elevated level of inhibin-α subunit is pro-tumourigenic and pro-metastatic and associated with extracapsular spread in advanced prostate cancer
P. Balanathan et al.
BRITISH JOURNAL OF CANCER (2009)
Proteoglycan signaling co-receptors: Roles in cell adhesion, migration and invasion
Karthikeyan Mythreye et al.
CELLULAR SIGNALLING (2009)
Peptide inhibitors of transforming growth factor-β enhance the efficacy of antitumor immunotherapy
Diana Llopiz et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Endogenous Betaglycan Is Essential for High-Potency Inhibin Antagonism in Gonadotropes
Ezra Wiater et al.
MOLECULAR ENDOCRINOLOGY (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
The type III TGF-β receptor regulates epithelial and cancer cell migration through β-arrestin2-mediated activation of Cdc42
Karthikeyan Mythreye et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
A gene sets approach for identifying prognostic gene signatures for outcome prediction
Seon-Young Kim et al.
BMC GENOMICS (2008)
TβRIII suppresses non-small cell lung cancer invasiveness and tumorigenicity
Elizabeth C. Finger et al.
CARCINOGENESIS (2008)
Suppression of inhibin A biological activity by alterations in the binding site for betaglycan
Yogeshwar Makanji et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
An Activin/Furin Regulatory Loop Modulates the Processing and Secretion of Inhibin α- and βB-Subunit Dimers in Pituitary Gonadotrope Cells
Monica Antenos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Endoglin Promotes Transforming Growth Factor β-mediated Smad 1/5/8 Signaling and Inhibits Endothelial Cell Migration through Its Association with GIPC
Nam Y. Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Endoglin expression in metastatic breast cancer cells enhances their invasive phenotype
D. Oxmann et al.
ONCOGENE (2008)
Immunohistochemical similarities between pancreatic mucinous cystic tumor and ovarian mucinous cystic tumor
Yutaka Suzuki et al.
PANCREAS (2008)
Loss of type III transforming growth factor β receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression
Kelly J. Gordon et al.
CARCINOGENESIS (2008)
Coronary vessel development is dependent on the type III transforming growth factor β receptor
Leigh A. Compton et al.
CIRCULATION RESEARCH (2007)
The interaction of endoglin with β-arrestin2 regulates transforming growth factor-β-mediated ERK activation and migration in endothelial cells
Nam Y. Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile
M. M. Baldewijns et al.
BRITISH JOURNAL OF CANCER (2007)
Loss of betaglycan expression in ovarian cancer: Role in motility and invasion
Nadine Hempel et al.
CANCER RESEARCH (2007)
Granulosa cell tumors of the ovary: The clinical value of serum inhibin A and B levels in a large single center cohort
C. H. Mom et al.
GYNECOLOGIC ONCOLOGY (2007)
Inhibin A and B in vitro bioactivities are modified by their degree of glycosylation and their affinities to betaglycan
Yogeshwar Makanji et al.
ENDOCRINOLOGY (2007)
Inhibin as a diagnostic marker for ovarian cancer
David N. Robertson et al.
CANCER LETTERS (2007)
The type III transforming growth factor-β receptor as a novel tumor suppressor gene in prostate cancer
Ryan S. Turley et al.
CANCER RESEARCH (2007)
Vascular endothelial growth factor and endoglin (CD-105) in gastric cancer
Nikolaos I. Nikiteas et al.
GASTRIC CANCER (2007)
The type III TGF-beta receptor suppresses breast cancer progression
Mei Dong et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Cell-surface co-receptors: emerging roles in signaling and human disease
KC Kirkbride et al.
TRENDS IN BIOCHEMICAL SCIENCES (2005)
Systemic administration of a soluble betaglycan suppresses tumor growth, angiogenesis, and matrix metalloproteinase-9 expression in a human xenograft model of prostate cancer
A Bandyopadhyay et al.
PROSTATE (2005)
Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival
HY Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Inhibin α-subunit (INHA) gene and locus changes in paediatric adrenocortical tumours from TP53 R337H mutation heterozygote carriers
CA Longui et al.
JOURNAL OF MEDICAL GENETICS (2004)
Re-evaluation of inhibin at subunit as a tumour suppressor in prostate cancer
GP Risbridger et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2004)
Cancer progression:: is inhibin α from Venus or Mars?
EMA Ball et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
Smad-dependent and Smad-independent pathways in TGF-β family signalling
R Derynck et al.
NATURE (2003)
β-arrestin 2 mediates endocytosis of type III TGF-β receptor and down-regulation of its signaling
W Chen et al.
SCIENCE (2003)
Convergence of Wnt signaling and steroidogenic factor-1 (SF-1) on transcription of the rat inhibin α gene
BM Gummow et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Heart and liver defects and reduced transforming growth factor β2 sensitivity in transforming growth factor β type III receptor-deficient embryos
KL Stenvers et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Inducible expression of human endoglin during inflammation and wound healing in vivo
E Torsney et al.
INFLAMMATION RESEARCH (2002)
Betaglycan binds inhibin and can mediate functional antagonism of activin signalling
KA Lewis et al.
NATURE (2000)
Identification of a binding site on the type II activin receptor for activin and inhibin
PC Gray et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
KEGG: Kyoto Encyclopedia of Genes and Genomes
M Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2000)
Endoglin, an ancillary TGF beta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development
HM Arthur et al.
DEVELOPMENTAL BIOLOGY (2000)
Share Paper
